Brief: China Regenerative Medicine International Says Qtrly Loss Attributable HK$36.7 Mln
15/05/2019 15:30
May 15 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* QTRLY LOSS ATTRIBUTABLE HK$36.7 MILLION VERSUS LOSS OF
53.4
MILLION
Source text for Eikon: ID:nHKSbjl8yY
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital